These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 39278716)

  • 1. Exploring the Association Between Atopic Dermatitis and Malignancy: A Comprehensive Review with Therapeutic Strategies.
    Drum DL; Wan LS; Jallorina AG; Lee-Wong MF
    Dermatol Clin; 2024 Oct; 42(4):625-634. PubMed ID: 39278716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Therapeutic Approaches and Targets for the Treatment of Atopic Dermatitis.
    Pescitelli L; Rosi E; Ricceri F; Pimpinelli N; Prignano F
    Curr Pharm Biotechnol; 2021; 22(1):73-84. PubMed ID: 32525769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-4 and IL-13 Inhibition in Atopic Dermatitis.
    Matsunaga MC; Yamauchi PS
    J Drugs Dermatol; 2016 Aug; 15(8):925-9. PubMed ID: 27537991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-13 antagonists in the treatment of atopic dermatitis.
    Tubau C; Puig L
    Immunotherapy; 2021 Mar; 13(4):327-344. PubMed ID: 33430628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dupilumab after the 2017 approval for the treatment of atopic dermatitis: what's new and what's next?
    van der Schaft J; Thijs JL; de Bruin-Weller MS; Balak DMW
    Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):341-349. PubMed ID: 31145194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative safety analysis of anti-interleukin-4/interleukin-13 inhibitors and Janus Kinase inhibitors in atopic dermatitis.
    Bao A; Su HJ; Wan J
    J Am Acad Dermatol; 2024 Oct; 91(4):768-771. PubMed ID: 38971182
    [No Abstract]   [Full Text] [Related]  

  • 7. Dupilumab, A Monoclonal Antibody for Atopic Dermatitis: A Review of Current Literature.
    Blakely K; Gooderham M; Papp K
    Skin Therapy Lett; 2016 Mar; 21(2):1-5. PubMed ID: 27223113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight gain in patients with severe atopic dermatitis treated with dupilumab: a cohort study.
    Johansson EK; Ivert LU; Bradley B; Lundqvist M; Bradley M
    BMC Dermatol; 2020 Sep; 20(1):8. PubMed ID: 32962676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dupilumab in the treatment of moderate-to-severe atopic dermatitis.
    Kraft M; Worm M
    Expert Rev Clin Immunol; 2017 Apr; 13(4):301-310. PubMed ID: 28165826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy.
    D'Erme AM; Romanelli M; Chiricozzi A
    Drug Des Devel Ther; 2017; 11():1473-1480. PubMed ID: 28553077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An updated reappraisal of dupilumab in children and adolescents with moderate-severe atopic dermatitis.
    Ciprandi G; Licari A; Tosca MA; Miraglia Del Giudice M; Belloni Fortina A; Marseglia GL
    Pediatr Allergy Immunol; 2024 Jun; 35(6):e14181. PubMed ID: 38934228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dupilumab for Moderate-to-Severe Atopic Dermatitis.
    Vangipuram R; Tyring SK
    Skin Therapy Lett; 2017 Nov; 22(6):1-4. PubMed ID: 29091379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Interleukins 4 and/or 13 in the Pathophysiology and Treatment of Atopic Dermatitis.
    Silverberg JI; Kantor R
    Dermatol Clin; 2017 Jul; 35(3):327-334. PubMed ID: 28577802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asthma and Atopic Dermatitis: A Review of Targeted Inhibition of Interleukin-4 and Interleukin-13 As Therapy for Atopic Disease.
    Buzney CD; Gottlieb AB; Rosmarin D
    J Drugs Dermatol; 2016 Feb; 15(2):165-71. PubMed ID: 26885783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologics for Atopic Dermatitis.
    Boguniewicz M
    Immunol Allergy Clin North Am; 2020 Nov; 40(4):593-607. PubMed ID: 33012322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two Cancer Patients Receiving Dupilumab for Treatment of Atopic Dermatitis.
    Fowler E; Rosen J; Lev-Tov H; Yosipovitch G
    Acta Derm Venereol; 2019 Sep; 99(10):899-900. PubMed ID: 31037315
    [No Abstract]   [Full Text] [Related]  

  • 17. Dupilumab for treatment of atopic dermatitis.
    Seegräber M; Srour J; Walter A; Knop M; Wollenberg A
    Expert Rev Clin Pharmacol; 2018 May; 11(5):467-474. PubMed ID: 29557246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of Skin Barrier Abnormalities with IL4/13 Inhibitors and Jak Inhibitors in Atopic Dermatitis: A Systematic Review.
    Chatzigeorgiou I; Koumaki D; Vakirlis E; Papadimitriou I; Gregoriou S
    Medicina (Kaunas); 2024 Aug; 60(8):. PubMed ID: 39202657
    [No Abstract]   [Full Text] [Related]  

  • 19. Innovation in Atopic Dermatitis: From Pathogenesis to Treatment.
    Munera-Campos M; Carrascosa JM
    Actas Dermosifiliogr (Engl Ed); 2020 Apr; 111(3):205-221. PubMed ID: 31964499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and Management of Conjunctivitis for the Dermatologist.
    Gooderham M; McDonald J; Papp K
    J Cutan Med Surg; 2018; 22(2):200-206. PubMed ID: 29191053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.